#234 Iron-ing Out the Wrinkles in Anemia Management
CLINICAL QUESTION
Are newer oral iron formulations (iron polysaccharide complex or heme iron polypeptide) better than ferrous salts for iron deficiency anemia (IDA)?
BOTTOM LINE
Newer iron formulations appear inferior to older ferrous salts. Ferrous salts improve hemoglobin up to 10-20g/L more and perhaps one in five more attaining IDA resolution at 3 months. Evidence that newer formulations have less adverse effects is inconsistent.
Reading Tools for Practice Article can earn you MainPro+ Credits
Join NowAlready a CFPCLearn Member? Log in
EVIDENCE
Randomized controlled trials. Differences statistically significant unless indicated.
- General population adults:
- 80 patients (92% female, mean age 39):1 iron polysaccharide (Niferex™) versus ferrous fumarate, both ~150mg/day elemental iron. After 12 weeks:
- Ferrous fumarate improved hemoglobin (28.4g/L) more than iron polysaccharide (6g/L), and had better serum ferritin, mean corpuscular volume, and transferrin saturation but more nausea (31% versus 3%).
- 80 children (mean age 23 months):2 Iron polysaccharide (NovaFerrum™) versus ferrous sulfate, both 3mg/kg/day elemental iron.
- At 12 weeks, ferrous sulphate improved hemoglobin more (10g/L), resolved IDA (29% vs 6%, Number Needed to Treat=5), caused less diarrhea (35% versus 58%).
- Smaller trials of adults (n=43)3 and premature infants (n=32)4: iron polysaccharide and ferrous salts were no different in hemoglobin improvement after 4-6 weeks.
- 80 patients (92% female, mean age 39):1 iron polysaccharide (Niferex™) versus ferrous fumarate, both ~150mg/day elemental iron. After 12 weeks:
- Subgroups:
- Dialysis patients: At 6 months, ferrous salts no different from newer formulations on transferrin saturation5,6 or proportion of iron-replete patients.5
- Ferritin ~(160µg/L) better with ferrous sulfate than heme iron (Proferrin ES™).5
- Post-gastric bypass (n=14):7 Ferrous sulfate improved hemoglobin after 8 weeks, but heme iron (Proferrin ES™) did not.
- Blood Donors (n=97):8 and pregnant patients (n=90)9: Heme iron with ferrous fumarate (Hemofer™) no different from higher doses ferrous fumarate alone in achieving anemia outcomes; 8,9 ferrous fumarate alone caused more constipation (35% versus 14%).8
- Dialysis patients: At 6 months, ferrous salts no different from newer formulations on transferrin saturation5,6 or proportion of iron-replete patients.5
- Multiple limitations including underpowered,2,4,6-9 multiple outcomes,1-9 non-intention-to-treat.1,2,5
- Approximate costs/month for 100mg elemental iron/day10: ferrous fumarate/sulphate (generics $5-10), ferrous fumarate (Palafer™ $35), iron polysaccharide complexes (Feramax™ $35).
- To reduce iron-related gastrointestinal upset: lower dose11; use another ferrous salt (incidence of adverse effects: ferrous gluconate 30%, sulfate 32%, fumarate 47%);12 alternate day dosing.13
Latest Tools for Practice
#379 Bumpin’ Up the Protection? RSV Vaccine in Pregnancy
How effective and safe is the respiratory syncytial virus (RSV) vaccine (AbrysvoTM) when given during pregnancy?
#378 Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?
What is the efficacy and safety of romosozumab in postmenopausal women with osteoporosis?
#377 How to slow the flow IV: Combined oral contraceptives
In premenopausal heavy menstrual bleeding due to benign etiology, do combined oral contraceptives (COC) improve patient outcomes?
